Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06632977 |
| Title | Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (PREDICT) |
| Acronym | PREDICT |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Alliance for Clinical Trials in Oncology |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Helen F Graham Cancer Center | Newark | Delaware | 19713 | United States | Details | |
| Medical Oncology Hematology Consultants PA | Newark | Delaware | 19713 | United States | Details | |
| Mount Sinai Hospital | New York | New York | 10029 | United States | Details | |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| West Virginia University Charleston Division | Charleston | West Virginia | 25304 | United States | Details |